Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistanceJennifer S. Carew, John L. Cleveland, Charissa N. Kahue et al.|Blood|2007Cited by 485